TSXV - Free Realtime Quote CAD

Entourage Health Corp. (ENTG.V)

Compare
0.0050
0.0000
(0.00%)
As of 9:52:52 AM EST. Market Open.
Loading Chart for ENTG.V
DELL
  • Previous Close 0.0050
  • Open 0.0050
  • Bid --
  • Ask 0.0100 x --
  • Day's Range 0.0050 - 0.0050
  • 52 Week Range 0.0050 - 0.0200
  • Volume 35,000
  • Avg. Volume 204,627
  • Market Cap (intraday) 1.542M
  • Beta (5Y Monthly) 1.06
  • PE Ratio (TTM) --
  • EPS (TTM) -0.1400
  • Earnings Date Apr 28, 2025 - May 2, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Entourage Health Corp. processes, produces, and distributes cannabis products for medical, adult-use, and bulk sales markets in Canada. It offers cannabis products, such as dried flower, pre-rolls, vapes, cannabis oils, topicals, soft chews, chewing gum, and micro inhalers. The company sells its products under the Color Cannabis, Saturday Cannabis, Starseed Medicinal, Dime Bag, Syndicate, Mary's Medicinals, and Royal City Cannabis brand names. The company was formerly known as WeedMD Inc. and changed its name to Entourage Health Corp. in July 2021. Entourage Health Corp. is headquartered in Aylmer, Canada.

entouragehealthcorp.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: ENTG.V

View More

Performance Overview: ENTG.V

Trailing total returns as of 2/7/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

ENTG.V
0.00%
S&P/TSX Composite index
3.79%

1-Year Return

ENTG.V
50.00%
S&P/TSX Composite index
21.93%

3-Year Return

ENTG.V
94.44%
S&P/TSX Composite index
20.13%

5-Year Return

ENTG.V
99.32%
S&P/TSX Composite index
43.91%

Compare To: ENTG.V

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ENTG.V

View More

Valuation Measures

As of 2/6/2025
  • Market Cap

    1.54M

  • Enterprise Value

    179.83M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.04

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    4.34

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -107.45%

  • Return on Assets (ttm)

    -36.79%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    40.67M

  • Net Income Avi to Common (ttm)

    -43.7M

  • Diluted EPS (ttm)

    -0.1400

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.59M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -17.58M

Research Analysis: ENTG.V

View More

People Also Watch